E Fund Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $829K | Sell |
2,739
-56
| -2% | -$16.9K | 0.04% | 185 |
|
|
2025
Q1 | $926K | Buy |
2,795
+440
| +19% | +$146K | 0.04% | 177 |
|
|
2024
Q4 | $727K | Sell |
2,355
-508
| -18% | -$157K | 0.04% | 182 |
|
|
2024
Q3 | $608K | Buy |
2,863
+651
| +29% | +$138K | 0.03% | 180 |
|
|
2024
Q2 | $620K | Buy |
2,212
+514
| +30% | +$144K | 0.03% | 158 |
|
|
2024
Q1 | $453K | Sell |
1,698
-608
| -26% | -$162K | 0.03% | 171 |
|
|
2023
Q4 | $534K | Sell |
2,306
-21
| -0.9% | -$4.86K | 0.03% | 148 |
|
|
2023
Q3 | $340K | Buy |
2,327
+644
| +38% | +$94.1K | 0.03% | 196 |
|
|
2023
Q2 | $389K | Buy |
1,683
+84
| +5% | +$19.4K | 0.03% | 180 |
|
|
2023
Q1 | $387K | Sell |
1,599
-3,933
| -71% | -$952K | 0.03% | 177 |
|
|
2022
Q4 | $1.61M | Buy |
5,532
+994
| +22% | +$289K | 0.13% | 66 |
|
|
2022
Q3 | $295K | Buy |
4,538
+968
| +27% | +$62.9K | 0.03% | 241 |
|
|
2022
Q2 | $256K | Buy |
3,570
+1,248
| +54% | +$89.5K | 0.02% | 259 |
|
|
2022
Q1 | $228K | Buy |
+2,322
| New | +$228K | 0.01% | 271 |
|